Pfizer Picks China Firm Involved in Drug Recall for Covid Pill

Pfizer Inc. has picked a Chinese drug-making giant once embroiled in a global medicines recall for supplying tainted ingredients to make its Covid-19 antiviral pill in the country. Zhejiang Huahai Pharmaceutical Co. will produce and sell Paxlovid in mainland China for five years, the companies said Thursday in separate statements. Pfizer will provide ingredients to make nirmatrelvir, the antiviral portion of the drug, and ritonavir, which slows the antiviral’s breakdown in the body. Huahai will manufacture and combine the two into Paxlovid.